Mode
Text Size
Log in / Sign up
N/A N=60 Randomized Single-blind

Examining the Ease of Intubation Using the Parker Flex-Tip® or a Standard Endotracheal Tube

Larynx

Enrolled (actual)
60
Serious AEs
0.0%
Results posted
Dec 2011
Primary outcome: Primary: Ease of Intubation, as Measured by Time in Seconds for ETT Insertion — 10.8; 12.7 Seconds

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Mallinckrodt (ETT) (Device); Parker Flex-Tip (ETT) (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University Hospitals Cleveland Medical Center
Primary completion
May 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Ease of Intubation, as Measured by Time in Seconds for ETT Insertion
10.8; 12.7
PRIMARY
Ease of Intubation, as Measured by Number of ETT Redirections
0.7; 1.3
PRIMARY
Ease of Intubation, as Measured by an Ease of ETT Insertion Score.
12.7; 17.8

Summary

The purpose of the study is to determine if there are differences related to ease of intubation reported by clinicians who use the Parker Flex-Tip® endotracheal tubes(ETT)compared to the standard Mallinckrodt® (ETT). The problem is two (ETTs), the Parker Flex-Tip® and the Mallinckrodt®, are currently available for use in operative suites for intubation, but few studies have compared these devices with each other. Two research questions to be answered in the study are 1. Is there a difference in the ease of intubation when the Parker Flex-Tip® (ETT) is used when compared to the standard Mallinckrodt® (ETT)? and 2. Are there differences in the number of successful intubations when comparing the Parker Flex-Tip® (ETT) and the standard Mallinckrodt® (ETT)? The hypotheses are the use of the Parker Flex-Tip® (ETT) will demonstrate: 1. Fewer seconds to intubate the trachea. 2. Higher self-reported ease of placement scores and 3. Fewer redirections to intubate the trachea. The number of successful intubations is expected to be the same in both arms of the study.

Eligibility Criteria

Inclusion Criteria

  • Subjects that are males and non-pregnant females > or equal to 18 years of age that require a general anesthetic with an (ETT).
  • Able to give informed consent (adults, English reading and speaking)

Exclusion Criteria

  • Any subject on examination with a mallampati III or greater and/or history of difficult intubation.
  • Any subject with an American Society of Anesthesiologist classification greater than 3.
  • Any subject needing rapid sequence induction.
  • Any subject that the anesthesia provider considers the GlideScope® to be contraindicated.
  • Any subject that an anesthesia provider feels for any reason at any time is not appropriate for inclusion in this study.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01263873). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search